WINDLAS BIOTECH
|
The Current P/S Ratio of WINDLAS BIOTECH is 2.48.
Share Price | ₹898.5 | Jul 11,2025 |
Market Cap | ₹1,886.7 Cr | |
Sales-TTM | ₹759.9 Cr | TTM-Consolidated Results |
Price/Sales | 2.48x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of WINDLAS BIOTECH
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,886.7 Cr] as on Jul 11,2025
(/) Sales [ ₹759.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.48x ]
Thus, for WINDLAS BIOTECH , the investors are currently willing to pay '2.48 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of WINDLAS BIOTECH !
The chart below summarizes the trend in P/S Ratio of WINDLAS BIOTECH over the last five years.
Historical PS (Price/Sales) ratio chart of WINDLAS BIOTECH
PS Ratio Performance Analysis for WINDLAS BIOTECH
- WINDLAS BIOTECH 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.29x.
- WINDLAS BIOTECH 's operated at median p/e ratio of 0.98x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WINDLAS BIOTECH 's p/e ratio peaked in Mar2025 at 2.87x.
- WINDLAS BIOTECH 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does WINDLAS BIOTECH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
WINDLAS BIOTECH | 759.9 | 2.48 | 1,886.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.63 | 401,289.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 19.38 | 181,397.0 |
CIPLA LTD | 27,547.6 | 4.35 | 119,955.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 9.74 | 112,132.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.21 | 104,657.0 |
MANKIND PHARMA LTD | 12,279.3 | 8.67 | 106,401.0 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.24 | 98,570.7 |
LUPIN LTD | 22,707.9 | 3.81 | 86,442.7 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.06 | 65,308.2 |
ABBOTT INDIA LTD | 6,409.2 | 11.41 | 73,118.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WINDLAS BIOTECH 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.06x |
Max industry PS | 19.38x |
Median industry PS | 4.35x |
Average industry PS | 7.00x |
You may also like the below Video Courses